12/15-Lipoxygenase (12/15-LO(X); EC is a non-heme, iron-containing enzyme that dioxygenates polyunsaturated fatty acids into bioactive lipid derivatives, more specifically: it can metabolize arachidonic acid to generate corresponding hydroxides such as 12-hydroxyeicosatetraenoic acid (12-HETE) and 15-HETE. 12/15-LOX is widely expressed in the CNS, and has been demonstrated to be involved in the pathogenesis of various neurological diseases. 12/15-LOX exerts a regulatory role in Alzheimer’s disease, an inflammatory and neurodegenerative disease[1]. Additionally, human 12/15-LOX (aka 15-LOX-1) is also an attractive therapeutic target for its role in atherogenesis, diabetes, newborn periventricular leukomalacia, breast cancer and stroke[2].

[1] J. Xu et al. Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPARβ/δ: a potential therapeutic role for CNS autoimmune disease. Cell Death Dis. 2013, 4, e569.
[2] G. Rai et al. Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies. J. Med. Chem. 2014, 57, 4035-4048.

6 Item(s)

per page
Axon ID Name Description From price
3256 Zileuton Potent and orally active inhibitor of 5-lipoxygenase (5-LOX) €50.00
2844 ThioLox Inhibitor of 15-lipoxygenase-1 (15-LOX-1) €120.00
2873 ML 355 Potent and selective inhibitor of 12-lipoxygenase (LOX) €95.00
2312 ML 351 Potent and selective inhibitor of 12/15-lipoxygenase (LOX) €125.00
3176 Diethylcarbamazine citrate Filaricidal drug €40.00
2989 15-LOX-1 inhibitor i472 Inhibitor of 15-lipoxygenase-1 (15-LOX-1) €170.00

6 Item(s)

per page
Please wait...